Publications

2023

318.
Gershoni A., Hassin O., Nataraj N. B. et al. (2023) Molecular Oncology. 17, 12, p. 2675-2693  Abstract [All authors]
317.
Michael D., Feldmesser E., Gonen C. et al. (2023) FEBS Letters. 597, 9, p. 1233-1245  Abstract [All authors]
316.
Vitale I., Pietrocola F., Guilbaud E. et al. (2023) Cell Death and Differentiation. 30, 5, p. 1097-1154  Abstract [All authors]
315.
Venghateri J. B., Dassa B., Morgenstern D., Shreberk-Shaked M., Oren M. & Geiger B. (2023) Cell Death & Disease. 14, 4, 290.  Abstract

2022

314.
Aylon Y., Furth N., Mallel G. et al. (2022) Nature Communications. 13, 1, 7199.  Abstract [All authors]
313.
Noronha A., Belugali Nataraj N., Sang Lee J. et al. (2022) Cancer Discovery. 12, 11, p. 2666-2683  Abstract [All authors]
312.
Hassin O. & Oren M. (2022) Nature reviews. Drug discovery. p. 1-18  Abstract
311.
Hassin O., Nataraj N. B., Shreberk-Shaked M. et al. (2022) Nature Communications. 13, 1, 2800.  Abstract [All authors]
310.
Mukherjee S., Maddalena M., Lü Y. et al. (2022) Proceedings of the National Academy of Sciences - PNAS. 119, 17, e211964411.  Abstract [All authors]
309.
Tuval A., Brilon Y., Azogy H. et al. (2022) Haematologica (Roma). 107, 11,  Abstract [All authors]

2021

308.
Ghosh S., Nataraj N. B., Noronha A. et al. (2021) Cell reports (Cambridge). 35, 8, 109181.  Abstract [All authors]
307.
Maddalena M., Mallel G., Nataraj N. B. et al. (2021) Proceedings of the National Academy of Sciences - PNAS. 118, 23, e202563111.  Abstract [All authors]

2020

306.
Shreberk-Shaked M., Dassa B., Sinha S. et al. (2020) Cancer Research. 80, 19, p. 4145-4157  Abstract [All authors]
305.
Hoshino A., Kim H. S., Bojmar L. et al. (2020) Cell. 182, 4, p. 1044-1061.e18  Abstract [All authors]
304.
Benor G., Fuks G., Chin S. et al. (2020) Molecular Oncology. 14, 8, p. 1640-1652  Abstract [All authors]
303.
Kadosh E., Snir-Alkalay I., Venkatachalam A. et al. (2020) Nature. 7827, p. 133-+  Abstract [All authors]

2019

302.
Oren M. (2019) Journal of Molecular Cell Biology. 11, 7, p. 539-543  Abstract
301.
Shreberk-Shaked M. & Oren M. (2019) Molecular Oncology. 13, 6, p. 1335-1341  Abstract
300.
Hooda J., Novak M., Salomon M. P. et al. (2019) Cancer Research. 79, 4, p. 760-772  Abstract [All authors]

2018

299.
Furth N., Pateras I. S., Rotkopf R. et al. (2018) Life science alliance. 1, 5, 201800171.  Abstract [All authors]
298.
Kotler E., Segal E. & Oren M. (2018) Molecular & cellular oncology. 5, 6, 1511207.  Abstract
297.
Minzel W., Venkatachalam A., Fink A. et al. (2018) Cell. 175, 1, p. 171-185  Abstract [All authors]
296.
Kotler E., Shani O., Goldfeld G. et al. (2018) Molecular Cell. 71, 1, p. 178-190.e8  Abstract [All authors]
295.
Jethwa A., Slabicki M., Huellein J. et al. (2018) Blood. 131, 25, p. 2789-2802  Abstract [All authors]
294.
Arandkar S., Furth N., Elisha Y. et al. (2018) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 115, 25, p. 6410-6415  Abstract [All authors]
293.
Ghannam-Shahbari D., Jacob E., Kakun R. R. et al. (2018) Oncogene. 37, 17, p. 2213-2224  Abstract [All authors]
292.
Solomon H., Dinowitz N., Pateras I. S. et al. (2018) Oncogene. 37, 12, p. 1669-1684  Abstract [All authors]
291.
Galluzzi L., Vitale I., Aaronson S. A. et al. (2018) Cell Death and Differentiation. 25, 3, p. 486-541  Abstract [All authors]
290.
Furth N., Aylon Y. & Oren M. (2018) Cell Death and Differentiation. 25, p. 81-92  Abstract

2017

289.
Enuka Y., Feldman M. E., Chowdhury A. et al. (2017) Nucleic Acids Research. 45, 22, p. 12681–12699  Abstract [All authors]
288.
Aylon Y. & Oren M. (2017) Cancer Cell. 32, 4, p. 397-399  Abstract
287.
Spolverini A., Fuchs G., Bublik D. R. & Oren M. (2017) Oncogene. 36, 42, p. 5819-5828  Abstract
286.
Tovy A., Spiro A., McCarthy R. et al. (2017) GENES & DEVELOPMENT. 31, 10, p. 959-972  Abstract
[All authors]
285.
Tarcic O., Granit R. Z., Pateras I. S. et al. (2017) Cell Death and Differentiation. 24, 4, p. 694-704  Abstract [All authors]
284.
Bublik D. R., Bursac S., Sheffer M. et al. (2017) Proceedings of the National Academy of Sciences of the United States of America. 114, 4, p. E496-E505  Abstract [All authors]

2016

283.
p53 mutations promote proteasomal activity
Oren M. & Kotler E. (2016) Nature Cell Biology. 18, 8, p. 833-835  Abstract
282.
Stock K., Estrada M. F., Vidic S. et al. (2016) Scientific Reports. 6, 28951.  Abstract [All authors]
281.
Aylon Y. & Oren M. (2016) Cell cycle (Georgetown, Tex.). 15, 17, p. 2248-55  Abstract
280.
Orsolic I., Jurada D., Pullen N., Oren M., Eliopoulos A. G. & Volarevic S. (2016) Seminars in Cancer Biology. 37-38, p. 36-50  Abstract
279.
Oren M., Tal P. & Rotter V. (2016) AGING-US. 8, 6, p. 1159-1160  Abstract
278.
Aylon Y., Gershoni A., Rotkopf R. et al. (2016) GENES & DEVELOPMENT. 30, 7, p. 786-97  Abstract [All authors]
277.
Yaeger R., Shah M. A., Miller V. A. et al. (2016) Gastroenterology. 151, 2, p. 278-287.e6  Abstract [All authors]
276.
Cancer therapeutic approach based on conformational stabilization of mutant p53 protein by small peptides
Tal P., Eizenberger S., Cohen E., Goldfinger N., Pietrokovski S., Oren M. & Rotter V. (2016) Oncotarget. 7, 11, p. 11817-11837  Abstract
275.
Hoffman Y., Bublik D. R., Ugalde A. P., Elkon R., Biniashvili T., Agami R., Oren M. & Pilpel Y. (2016) PLoS Genetics. p. 260-262  Abstract
274.
Tarcic O., Pateras I. S., Cooks T. et al. (2016) Cell Reports. 14, 6, p. 1462-1476  Abstract [All authors]

2015

273.
Harel S., Ben-Moshe N., Aylon Y. et al. (2015) Cell Death and Differentiation. 22, p. 1328-1340  Abstract [All authors]
272.
Pribluda A., Elyada E., Wiener Z. et al. (2015) Cancer Cell. 27, 6, p. 877-878  Abstract
[All authors]
271.
Fuchs G., Voichek Y., Rabani M., Benjamin S., Gilad S., Amit I. & Oren M. (2015) Nature Protocols. 10, 4, p. 605-618  Abstract
270.
Furth N., Bossel Ben-Moshe B. N., Pozniak Y., Porat Z., Geiger T., Domany E., Aylon Y. & Oren M. (2015) Genes and Development. 29, p. 2325-2330  Abstract
269.
Oren M. & Arundkar S. C. (2015) Leukemia. 29, 10, p. 2015-2023  Abstract
268.
Golomb L., Sagiv A., Pateras I., Maly A., Krizhanovsky V., Gorgoulis V., Oren M. & Ben-Yehuda A. (2015) Cell Death and Differentiation. 22, 11, p. 1764-1774  Abstract

2014

267.
Lasry A., Aran D., Zinger A. et al. (2014) Cytokine. 70, 1, p. 22-22  Abstract
[All authors]
266.
Fuchs G., Hollander D., Voichek Y., Ast G. & Oren M. (2014) Genome Research. 24, 10, p. 1572-1583  Abstract
265.
Cooks T., Harris C. & Oren M. (2014) Carcinogenesis. 35, 8, p. 1680-1690  Abstract
264.
Golomb L., Volarevic S. & Oren M. (2014) FEBS Letters. 588, 16, p. 2571-2579  Abstract
263.
Fuchs G. & Oren M. (2014) Biochimica Et Biophysica Acta-Gene Regulatory Mechanisms. 1839, 8, p. 694-701  Abstract
262.
Weilbacher A., Gutekunst M., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2014) Cell Death & Disease. 5, e1318.  Abstract
261.
Hoffman Y., Pilpel Y. & Oren M. (2014) Journal of Molecular Cell Biology. 6, 3, p. 192-197  Abstract
260.
Pathways and therapeutic targets in melanoma
Shtivelman E., Davies M. A., Hwu P., Yang J., Lotem M., Oren M., Flaherty K. T. & Fisher D. E. (2014) Oncotarget. 5, 7, p. 1701-1752  Abstract
259.
Aylon Y., Sarver A., Tovy A., Ainbinder E. & Oren M. (2014) Cell Death and Differentiation. 21, 4, p. 624-633  Abstract
258.
Hoffman Y., Bublik D. R., Pilpel Y. & Oren M. (2014) Cell Death and Differentiation. 21, 2, p. 302-309  Abstract
257.
Fuchs G., Voichek Y., Benjamin S., Gilad S., Amit I. & Oren M. (2014) GENOME BIOLOGY. 15, 5, R69.  Abstract
256.
Weingarten-Gabbay S., Khan D., Liberman N., Yoffe Y., Bialik S., Das S., Oren M. & Kimchi A. (2014) Oncogene. 33, 5, p. 611-618  Abstract

2013

255.
Golomb L. & Oren M. (2013) Cell Death and Differentiation. 20, 11, p. 1442-1443  Abstract
254.
Fausti F., Di Agostino A. S., Cioce M. et al. (2013) Cell Death and Differentiation. 20, 11, p. 1498-1509  Abstract
[All authors]
253.
Suzuki H., Yabuta N., Okada N., Torigata K., Aylon Y., Oren M. & Nojima H. (2013) Journal of Cell Science. 126, 19, p. 4358-4368  Abstract
252.
Shema E., Nikolov M., Haj-Yahya M. et al. (2013) Cell Reports. 4, 3, p. 601-608  Abstract [All authors]
251.
Pribluda A., Elyada E., Wiener Z. et al. (2013) Cancer Cell. 24, 2, p. 242-256  Abstract [All authors]
250.
Cooks T., Pateras I. S., Tarcic O. et al. (2013) Cancer Cell. 23, 5, p. 634-646  Abstract [All authors]
249.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013)  Abstract
248.
Hoffman Y., Dahary D., Bublik D. R., Oren M. & Pilpel Y. (2013) Bioinformatics. 29, 7, p. 894-902  Abstract
247.
Gutekunst M., Mueller T., Weilbacher A., Dengler M. A., Bedke J., Kruck S., Oren M., Aulitzky W. E. & van der Kuip d. K. H. (2013) Cancer Research. 73, 5, p. 1460-1469  Abstract

2012

246.
Hornung G., Bar-Ziv R., Rosin D., Tokuriki N., Tawfik D., Oren M. & Barkai N. (2012) Genome Research. 22, 12, p. 2409-2417  Abstract
245.
Bursac S., Brdovcak M. C., Pfannkuchen M. et al. (2012) Proceedings of the National Academy of Sciences of the United States of America. 109, 50, p. 20467-20472  Abstract [All authors]
244.
Schmid J. O., Dong M., Haubeiss S. et al. (2012) Cancer Research. 72, 22, p. 5824-5832  Abstract
[All authors]
243.
Fuchs G., Shema E., Vesterman R. et al. (2012) Molecular Cell. 46, 5, p. 662-673  Abstract [All authors]
242.
Hornung G., Oren M. & Barkai N. (2012) Molecular Cell. 46, 3, p. 362-368  Abstract
241.
Bublik D. R. & Oren M. (2012) EMBO Reports. 13, 4, p. 282-283  Abstract
240.
Zwang Y., Oren M. & Yarden Y. (2012) Cancer Research. 72, 5, p. 1051-1054  Abstract
239.
Haj-Yahya M., Eltarteer N., Ohayon S., Shema E., Kotler E., Oren M. & Brik A. (2012) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 51, 46, p. 11535-11539  Abstract
238.
Golomb L., Bublik D. R., Wilder S., Nevo R., Kiss V., Grabusic K., Volarevic S. & Oren M. (2012) Molecular Cell. 45, 2, p. 222-232  Abstract
237.
Blandino G., Deppert W., Hainaut P., Levine A., Lozano G., Olivier M., Rotter V., Wiman K. & Oren M. (2012) Cell Death and Differentiation. 19, 1, p. 180-183  Abstract

2011

236.
Furth N. & Oren M. (2011) Cell Cycle. 10, 18, p. 3054-3055  Abstract
235.
Shiloh Y., Shema E., Moyal L. & Oren M. (2011) FEBS Letters. 585, 18, p. 2795-2802  Abstract
234.
Golomb L. & Oren M. (2011) Cancer Cell. 20, 3, p. 283-284  Abstract
233.
Aylon Y. & Oren M. (2011) Molecular Oncology. 5, 4, p. 315-323  Abstract
232.
Tarocchi M., Hannivoort R., Hoshida Y. et al. (2011) Hepatology. 54, 2, p. 522-531  Abstract
[All authors]
231.
Shema E., Oren M. & Minsky N. (2011) Methods. 54, 3, p. 326-330  Abstract
230.
Dell'Orso S., Fontemaggi G., Stambolsky P. et al. (2011) Omics-A Journal Of Integrative Biology. 15, 5, p. 305-312  Abstract [All authors]
229.
Shema E., Kim J., Roeder R. G. & Oren M. (2011) Molecular Cell. 42, 4, p. 477-488  Abstract
228.
Zwang Y., Sas-Chen A., Drier Y. et al. (2011) Molecular Cell. 42, 4, p. 524-535  Abstract [All authors]
227.
Gutekunst M., Oren M., Weilbacher A., Dengler M. A., Markwardt C., Thomale J., Aulitzky W. E. & van der Kuip d. K. H. (2011) PLoS ONE. 6, 4,  Abstract
226.
Aylon Y. & Oren M. (2011) Current opinion in genetics & development. 21, 1, p. 86-92  Abstract
225.
Elyada E., Pribluda A., Goldstein R. E. et al. (2011) Nature. 470, 7334, p. 409-413  Abstract [All authors]
224.
Okada N., Yabuta N., Suzuki H., Aylon Y., Oren M. & Nojima H. (2011) Journal of Cell Science. 124, 1, p. 57-67  Abstract
223.
Goldstein I., Marcel V., Olivier M., Oren M., Rotter V. & Hainaut P. (2011) Cancer Gene Therapy. 18, 1, p. 2-11  Abstract

2010

222.
Addadi Y., Moskovits N., Granot D., Lozano G., Carmi Y., Apte R. N., Neeman M. & Oren M. (2010) Cancer Research. 70, 23, p. 9650-9658  Abstract
221.
Aylon Y., Ofir-Rosenfeld Y., Yabuta N., Lapi E., Nojima H., Lu X. & Oren M. (2010) GENES & DEVELOPMENT. 24, 21, p. 2420-2429  Abstract
220.
Scherz-Shouval R., Weidberg H., Gonen C., Wilder S., Elazar Z. & Oren M. (2010) Proceedings of the National Academy of Sciences of the United States of America. 107, 43, p. 18511-18516  Abstract
219.
Nili E. L., Field Y., Lubling Y., Widom J., Oren M. & Segal E. (2010) Genome Research. 20, 10, p. 1361-1368  Abstract
218.
Shalgi R., Pilpel Y. & Oren M. (2010) Trends in Genetics. 26, 6, p. 253-259  Abstract
217.
Schilling T., Kairat A., Melino G., Krammer P. H., Stremmel W., Oren M. & Müller M. (2010) Biochemical and Biophysical Research Communications. 394, 3, p. 817-823  Abstract
216.
Stambolsky P., Tabach Y., Fontemaggi G. et al. (2010) Cancer Cell. 17, 3, p. 273-285  Abstract [All authors]
215.
NF kappa B and p53: A life and death affair
Oren M. & Cooks T. (2010) Cell Cycle. 9, 6, p. 1027-1027  Abstract
214.
Oren M. & Rotter V. (2010) Cold Spring Harbor perspectives in biology. 2, 2,  Abstract
213.
Bar J., Moskovits N. & Oren M. (2010) SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY. 21, 1, p. 47-54  Abstract
212.
Christoffersen N. R., Shalgi R., Frankel L. B. et al. (2010) Cell Death and Differentiation. 17, 2, p. 236-245  Abstract [All authors]

2009

211.
Aylon Y., Yabuta N., Besserglick H., Buganim Y., Rotter V., Nojima H. & Oren M. (2009) Oncogene. 28, 50, p. 4469-4479  Abstract
210.
Skorta I., Oren M., Markwardt C., Gutekunst M., Aulitzky W. E. & van der Kuip d. K. H. (2009) Cancer Research. 69, 24, p. 9337-9345  Abstract
209.
Lavelin I., Beer A., Kam Z., Boner V., Oren M., Navon A. & Geiger B. (2009) PLoS ONE. 4, 12,  Abstract
208.
Levine A. J. & Oren M. (2009) Nature Reviews Cancer. 9, 10, p. 749-758  Abstract
207.
Schilling T., Schleithoff E. S., Kairat A., Melino G., Stremmel W., Oren M., Krammer P. H. & Mueller M. (2009) Biochemical and Biophysical Research Communications. 387, 2, p. 399-404  Abstract
206.
Coupling transcriptional and post-transcriptional miRNA regulation in the control of cell fate
Shalgi R., Brosh R., Oren M., Pilpel Y. & Rotter V. (2009) AGING-US. 1, 9, p. 762-770  Abstract
205.
Pirngruber J., Shchebet A., Schreiber L. et al. (2009) EMBO Reports. 10, 8, p. 894-900  Abstract [All authors]
204.
Bar J., Feniger-Barish R., Lukashchuk N. et al. (2009) Oncogene. 28, 6, p. 933-936  Abstract [All authors]

2008

203.
Brosh R., Shalgi R., Liran A. et al. (2008) Molecular Systems Biology. 4,  Abstract
[All authors]
202.
Ofir-Rosenfeld Y., Boggs K., Michael D., Kastan M. B. & Oren M. (2008) Molecular Cell. 32, 2, p. 180-189  Abstract
201.
Shema E., Tirosh I., Aylon Y. et al. (2008) GENES & DEVELOPMENT. 22, 19, p. 2664-2676  Abstract [All authors]
200.
Finkin S., Aylon Y., Anzi S., Oren M. & Shaulian E. (2008) Oncogene. 27, 32, p. 4411-4421  Abstract
199.
Bossi G., Marampon F., Maor-Aloni R., Zani B., Rotter V., Oren M., Strano S., Blandino G. & Sacchi A. (2008) Cell Cycle. 7, 12, p. 1870-1879  Abstract
198.
Minsky N., Shema E., Field Y., Schuster M., Segal E. & Oren M. (2008) Nature Cell Biology. 10, 4, p. 483-490  Abstract
197.
Abe Y., Oda-Sato E., Tobiume K., Kawauchi K., Taya Y., Okamoto K., Oren M. & Tanaka N. (2008) Proceedings of the National Academy of Sciences of the United States of America. 105, 12, p. 4838-4843  Abstract

2007

196.
Lantner F., Starlets D., Gore Y. et al. (2007) Blood. 110, 13, p. 4303-4311  Abstract
[All authors]
195.
Tiny actors, great roles - MicroRNAs in p53's service
Raver-Shapira N. & Oren M. (2007) Cell Cycle. 6, 21, p. 2656-2661  Abstract
194.
Reef S., Shifman O., Oren M. & Kimchi A. (2007) Oncogene. 26, 46, p. 6677-6683  Abstract
193.
Lu X., Ma O., Nguyen T., Joness S. N., Oren M. & Donehower L. A. (2007) Cancer Cell. 12, 4, p. 342-354  Abstract
192.
Aylon Y. & Oren M. (2007) Cell. 130, 4, p. 597-600  Abstract
191.
Shalgi R., Lieber D., Oren M. & Pilpel Y. (2007) PLoS Computational Biology. 3, 7, p. 1291-1304  Abstract
190.
Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z. & Oren M. (2007) Molecular Cell. 26, 5, p. 731-743  Abstract
189.
Weisz L., Oren M. & Rotter V. (2007) Oncogene. 26, 15, p. 2202-2211  Abstract
188.
Weisz L., Damalas A., Liontos M. et al. (2007) Cancer Research. 67, 6, p. 2396-2401  Abstract [All authors]
187.
Oren M. & Bartek J. (2007) Cell. 128, 5, p. 826-828  Abstract
186.
Shmueli A. & Oren M. (2007) Molecular Cell. 25, 6, p. 794-796  Abstract

2006

185.
Stambolsky P., Weisz L., Shats I., Klein Y. A., Goldfinger N., Oren M. & Rotter V. (2006) Cell Death and Differentiation. 13, 12, p. 2140-2149  Abstract
184.
Oren M. (2006) Ejc Supplements. 4, 12, p. 76-76  Abstract
183.
Moskovits N., Kalinkovich A., Bar J. & Oren M. (2006) Cancer Research. 66, 22, p. 10671-10676  Abstract
182.
Aylon Y., Michael D., Shmueli A., Yabuta N., Nojima H. & Oren M. (2006) GENES & DEVELOPMENT. 20, 19, p. 2687-2700  Abstract
181.
Rentsch C. A., Germann M., Wetterwald A. et al. (2006) European Urology Supplements. 5, 14, p. 790-790  Abstract
[All authors]
180.
Avkin S., Sevilya Z., Toube L., Geacintov N., Chaney S., Oren M. & Livneh Z. (2006) Molecular Cell. 22, 3, p. 407-413  Abstract
179.
Reef S., Zalckvar E., Shifman O., Bialik S., Sabanay H., Oren M. & Kimchi A. (2006) Molecular Cell. 22, 4, p. 463-475  Abstract
178.
Kogan I., Goldfinger N., Milyavsky M. et al. (2006) Cancer Research. 66, 7, p. 3531-3540  Abstract
[All authors]
177.
Margalit O., Amram H., Amariglio N. et al. (2006) Blood. 107, 4, p. 1599-1607  Abstract [All authors]
176.
Zalcenstein A., Weisz L., Stambolsky P., Bar J., Rotter V. & Oren M. (2006) Oncogene. 25, 3, p. 359-369  Abstract

2005

175.
Bar J., Lukaschuk N., Zalcenstein A., Wilder S., Seger R. & Oren M. (2005) Cell Death and Differentiation. 12, 12, p. 1578-1587  Abstract
174.
Muller M., Schilling T., Sayan A. et al. (2005) Cell Death and Differentiation. 12, 12, p. 1564-1577  Abstract [All authors]
173.
Shmueli A. & Oren M. (2005) Cell. 121, 7, p. 963-965  Abstract
172.
Gressner O., Schilling T., Lorenz K. et al. (2005) EMBO Journal. 24, 13, p. 2458-2471  Abstract [All authors]
171.
Oberst A., Rossi M., Salornoni P., Pandolfi P., Oren M., Melino G. & Bernassola F. (2005) Biochemical and Biophysical Research Communications. 331, 3, p. 707-712  Abstract
170.
Hershko T., Chaussepied M., Oren M. & Ginsberg D. (2005) Cell Death and Differentiation. 12, 4, p. 377-383  Abstract
169.
Wohlbold L., van der Kuip d. K. H., Moehring A., Granot G., Oren M., Vornlocher H. & Aulitzky W. (2005) Leukemia. 19, 2, p. 290-292  Abstract
168.
Damalas A., Weis L., Nordgard S. et al. (2005) Breast Cancer Research. 7, p. S53-S53  Abstract
[All authors]

2004

167.
Minsky N. & Oren M. (2004) Molecular Cell. 16, 4, p. 631-639  Abstract
166.
Weisz L., Zalcenstein A., Stambolsky P., Cohen Y., Goldfinger N., Oren M. & Rotter V. (2004) Cancer Research. 64, 22, p. 8318-8327  Abstract
165.
Daniely Y., Liao G., Dixon D., Linnoila R., Lori A., Randell S., Oren M. & Jetten A. (2004) American Journal Of Physiology-Cell Physiology. 287, 1, p. C171-C181  Abstract
164.
Levina E., Oren M. & Ben-Ze'ev A. (2004) Oncogene. 23, 25, p. 4444-4453  Abstract
163.
Wang X., Taplick J., Geva N. & Oren M. (2004) FEBS Letters. 561, 3-Jan, p. 195-201  Abstract
162.
Bar J., Cohen-Noyman E., Geiger B. & Oren M. (2004) Oncogene. 23, 12, p. 2128-2137  Abstract
161.
Fiucci G., Beaucourt S., Duflaut D. et al. (2004) Proceedings of the National Academy of Sciences of the United States of America. 101, 10, p. 3510-3515  Abstract
[All authors]
160.
Shmueli A. & Oren M. (2004) Molecular Cell. 13, 1, p. 4-5  Abstract

2003

159.
Zalcenstein A., Stambolsky P., Weisz L., Muller M., Wallach D., Goncharov T., Krammer P., Rotter V. & Oren M. (2003) Oncogene. 22, 36, p. 5667-5676  Abstract
158.
Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 431-442  Abstract
157.
Wang X., Zalcenstein A. & Oren M. (2003) Cell Death and Differentiation. 10, 4, p. 468-476  Abstract
156.
Ofek P., Ben-Meir D., Kariv-Inbal Z., Oren M. & Lavi S. (2003) Journal of Biological Chemistry. 278, 16, p. 14299-14305  Abstract
155.
Passer B., Nancy-Portebois V., Amzallag N. et al. (2003) Proceedings of the National Academy of Sciences of the United States of America. 100, 5, p. 2284-2289  Abstract [All authors]
154.
Michael D. Y. & Oren M. (2003) Seminars in Cancer Biology. 13, 1, p. 49-58  Abstract
153.
Nuclear factor-kappa B protects the liver against genotoxic stress and functions independently of p53
Lavon I., Pikarsky E., Gutkovich E., Goldberg I., Bar J., Oren M. & Ben-Neriah Y. (2003) Cancer Research. 63, 1, p. 25-30  Abstract

2002

152.
Blander G., Zalle N., Daniely Y., Taplick J., Gray M. & Oren M. (2002) Journal of Biological Chemistry. 277, 52, p. 50934-50940  Abstract
151.
OREN M., DAMALAS A., GOTTLIEB T. et al. (2002) Annals of the New York Academy of Sciences. 973, 1, p. 374-383  Abstract
[All authors]
150.
Courtois S., Verhaegh G., North S., Luciani M., Lassus P., Hibner U., Oren M. & Hainaut P. (2002) Oncogene. 21, 44, p. 6722-6728  Abstract
149.
Balass M., Kalef E., Maya R., Wilder S., Oren M. & Katchalski-Katzir E. (2002) Peptides. 23, 10, p. 1719-1725  Abstract
148.
PML is a target gene of β-catenin and plakoglobin, and coactivates β-catenin-mediated transcription
Shtutman M., Zhurinsky J., Oren M., Levina E. & Ben-Ze'ev A. (2002) Cancer Research. 62, 20, p. 5947-5954  Abstract
147.
Goldberg Z., Vogt Sionov S. R., Berger M., Zwang Y., Perets R., Van Etten E. R., Oren M., Taya Y. & Haupt Y. (2002) EMBO Journal. 21, 14, p. 3715-3727  Abstract
146.
Strano S., Fontemaggi G., Costanzo A. et al. (2002) Journal of Biological Chemistry. 277, 21, p. 18817-18826  Abstract [All authors]
145.
Wang X., Michael D. Y., de Murcia M. G. & Oren M. (2002) Journal of Biological Chemistry. 277, 18, p. 15697-15702  Abstract
144.
Folberg-Blum A., Sapir A., Shilo B. & Oren M. (2002) Oncogene. 21, 15, p. 2413-2417  Abstract
143.
Michael D. Y. & Oren M. (2002) Current opinion in genetics & development. 12, 1, p. 53-59  Abstract
142.
Gottlieb T., Leal J., Seger R., Taya Y. & Oren M. (2002) Oncogene. 21, 8, p. 1299-1303  Abstract

2001

141.
Susini L., Passer B., Amzallag-Elbaz N. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America. 98, 26, p. 15067-15072  Abstract
[All authors]
140.
Requirement for Mdm2 in the survival effects of Bcr-Abl and interleukin 3 in hematopoietic cells
Goetz A., van der Kuip d. K. H., Maya R., Oren M. & Aulitzky W. (2001) Cancer Research. 61, 20, p. 7635-7641  Abstract
139.
Sadot E., Geiger B., Oren M. & Ben-Ze'ev A. (2001) Molecular and Cellular Biology. 21, 20, p. 6768-6781  Abstract
138.
Damalas A., Kahan S., Shtutman M., Ben-Ze'ev A. & Oren M. (2001) EMBO Journal. 20, 17, p. 4912-4922  Abstract
137.
Maya R., Balass M., Kim S. et al. (2001) GENES & DEVELOPMENT. 15, 9, p. 1067-1077  Abstract [All authors]
136.
Strano S., Munarriz E., Rossi M. et al. (2001) Journal of Biological Chemistry. 276, 18, p. 15164-15173  Abstract [All authors]

2000

135.
The Warner syndrome protein contributes to induction of p53 by DNA damage
Blander G., Zalle N., Leal J., Bar-Or R., Yu C. & Oren M. (2000) FASEB Journal. 14, 14, p. 2138-2140  Abstract
134.
Reinstein E., Scheffner M., Oren M., Ciechanover A. & Schwartz A. (2000) Oncogene. 19, 51, p. 5944-5950  Abstract
133.
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Bar-Or R., Maya R., Segel L., Alon U., Levine A. & Oren M. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 21, p. 11250-11255  Abstract
132.
Ries S., Biederer C., Woods D., Shifman O., Shirasawa S., Sasazuki T., McMahon M., Oren M. & McCormick F. (2000) Cell. 103, 2, p. 321-330  Abstract
131.
Strano S., Munarriz E., Rossi M. et al. (2000) Journal of Biological Chemistry. 275, 38, p. 29503-29512  Abstract [All authors]
130.
Maya R. & Oren M. (2000) Oncogene. 19, 28, p. 3213-3215  Abstract
129.
Amson R., Lassalle J., Halley H. et al. (2000) Proceedings of the National Academy of Sciences of the United States of America. 97, 10, p. 5346-5350  Abstract
[All authors]
128.
de Rozieres R. S., Maya R., Oren M. & Lozano G. (2000) Oncogene. 19, 13, p. 1691-1697  Abstract

1999

127.
Oren M. (1999) Journal of Biological Chemistry. 274, 51, p. 36031-36034  Abstract
126.
Khosravi R., Maya R., Gottlieb T., Oren M., Shiloh Y. & Shkedy D. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 26, p. 14973-14977  Abstract
125.
Blander G., Kipnis J., Leal J., Yu C., Schellenberg G. & Oren M. (1999) Journal of Biological Chemistry. 274, 41, p. 29463-29469  Abstract
124.
Roperch J., Lethrone F., Prieur S. et al. (1999) Proceedings of the National Academy of Sciences of the United States of America. 96, 14, p. 8070-8073  Abstract
[All authors]
123.
Interaction of c-Abl and p73 alpha and their collaboration to induce apoptosis
Agami R., Blandino G., Oren M. & Shaul Y. (1999) Nature. 399, 6738, p. 809-813  Abstract
122.
Damalas A., Ben-Ze'ev A., Simcha I., Shtutman N., Leal J., Zhurinsky J., Geiger B. & Oren M. (1999) EMBO Journal. 18, 11, p. 3054-3063  Abstract
121.
Hot papers - Cancer research - Mdm2 promotes the rapid degradation of p53 by Y. Haupt, R. Maya, A. Kazaz, M. Oren and Regulation of p53 stability by Mdm2 by M.H.G. Kubbutat, S.N. Jones, K.H. Vousden - Comments
Oren M. & Vousden K. (1999) Scientist. 13, 12, p. 11-11  Abstract
120.
MDM2 suppresses p73 function without promoting p73 degradation
Zeng X., Chen L., Jost C. et al. (1999) Molecular and Cellular Biology. 19, 5, p. 3257-3266  Abstract [All authors]
119.
Unger T., Sionov R., Moallem E., Yee C., Howley P., Oren M. & Haupt Y. (1999) Oncogene. 18, 21, p. 3205-3212  Abstract
118.
Elkeles A., Juven-Gershon T., Israeli D., Wilder S., Zalcenstein A. & Oren M. (1999) Molecular and Cellular Biology. 19, 4, p. 2594-2600  Abstract
117.
Unger T., Juven-Gershon T., Moallem E., Berger M., Sionov R., Lozano G., Oren M. & Haupt Y. (1999) EMBO Journal. 18, 7, p. 1805-1814  Abstract
116.
Sionov R., Moallem E., Berger M., Kazaz A., Gerlitz O., Ben-Neriah Y., Oren M. & Haupt Y. (1999) Journal of Biological Chemistry. 274, 13, p. 8371-8374  Abstract
115.
Mdm2: The ups and downs
Juven-Gershon T. & Oren M. (1999) Molecular Medicine. 5, 2, p. 71-83  Abstract
114.
Oren M. & Rotter V. (1999) Cellular and Molecular Life Sciences. 55, 1, p. 9-11  Abstract
113.
Blandino G., Levine A. & Oren M. (1999) Oncogene. 18, 2, p. 477-485  Abstract

1998

112.
Muller M., Wilder S., Bannasch D. et al. (1998) Journal of Experimental Medicine. 188, 11, p. 2033-2045  Abstract [All authors]
111.
Hosokawa K., Aharoni D., Dantes A. et al. (1998) Endocrinology. 139, 11, p. 4688-4700  Abstract
[All authors]
110.
Gottlieb T. & Oren M. (1998) Seminars in Cancer Biology. 8, 5, p. 359-368  Abstract
109.
Wang Y., Blandino G., Oren M. & Givol D. (1998) Oncogene. 17, 15, p. 1923-1930  Abstract
108.
Gottlieb E. & Oren M. (1998) EMBO Journal. 17, 13, p. 3587-3596  Abstract
107.
Yardley G., Zauberman A., Oren M. & Jackson P. (1998) FEBS Letters. 430, 3, p. 171-175  Abstract
106.
The Mdm2 oncoprotein interacts with the cell fate regulator numb
Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y. & Oren M. (1998) Molecular and Cellular Biology. 18, 7, p. 3974-3982  Abstract
105.
Roperch J., Alvaro V., Prieur S. et al. (1998) Nature Medicine. 4, 7, p. 835-838  Abstract
[All authors]
104.
Oren M. (1998) Nature. 391, 6664, p. 233-234  Abstract
103.
Ori A., Zauberman A., Doitsh G., Paran N., Oren M. & Shaul Y. (1998) EMBO Journal. 17, 2, p. 544-553  Abstract

1997

102.
Shaulian E., Resnitzky D., Shifman O., Blandino G., Amsterdam A., Yayon A. & Oren M. (1997) Oncogene. 15, 22, p. 2717-2725  Abstract
101.
Zauberman A., Oren M. & Zipori D. (1997) Oncogene. 15, 14, p. 1705-1711  Abstract
99.
Israeli D., Tessler E., Haupt Y., Elkeles A., Wilder S., Amson R., Telerman A. & Oren M. (1997) EMBO Journal. 16, 14, p. 4384-4392  Abstract
98.
Friedman S., Shaulian E., Littlewood T., Resnitzky D. & Oren M. (1997) Oncogene. 15, 1, p. 63-70  Abstract
97.
Haupt Y., Maya R., Kazaz A. & Oren M. (1997) Nature. 387, 6630, p. 296-299  Abstract
96.
Ruaro E., Collavin L., DelSal G., Haffner R., Oren M., Levine A. & Schneider C. (1997) Proceedings of the National Academy of Sciences of the United States of America. 94, 9, p. 4675-4680  Abstract
95.
Gottlieb E., Haffner R., King A., Asher G., Gruss P., Lonai P. & Oren M. (1997) EMBO Journal. 16, 6, p. 1381-1390  Abstract
94.
Hansen R. & Oren M. (1997) Current opinion in genetics & development. 7, 1, p. 46-51  Abstract

1996

93.
Oren M. & Prives C. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1288, 3, p. R13-R19  Abstract
92.
p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells
Eizenberg O., FaberElman A., Gottlieb E., Oren M., Rotter V. & Schwartz M. (1996) Molecular and Cellular Biology. 16, 9, p. 5178-5185  Abstract
91.
Friedlander P., Haupt Y., Prives C. & Oren M. (1996) Molecular and Cellular Biology. 16, 9, p. 4961-4971  Abstract
90.
Tanaka N., Ishihara M., Lamphier M. et al. (1996) Nature. 382, 6594, p. 816-818  Abstract
[All authors]
89.
Nemani M., LinaresCruz G., BruzzoniGiovanelli H. et al. (1996) Proceedings of the National Academy of Sciences of the United States of America. 93, 17, p. 9039-9042  Abstract
[All authors]
88.
Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells
Bacus S., Yarden Y., Oren M. et al. (1996) Oncogene. 12, 12, p. 2535-2547  Abstract
[All authors]
87.
Gottlieb T. & Oren M. (1996) Biochimica Et Biophysica Acta-Reviews On Cancer. 1287, 3-Feb, p. 77-102  Abstract
86.
Abrogation of wild-type p53 mediated growth-inhibition by nuclear exclusion
Knippschild U., Oren M. & Deppert W. (1996) Oncogene. 12, 8, p. 1755-1765  Abstract
85.
Haupt Y., Barak Y. & Oren M. (1996) EMBO Journal. 15, 7, p. 1596-1606  Abstract
84.
Bowman T., Symonds H., Gu L., Yin C., Oren M. & VanDyke T. (1996) GENES & DEVELOPMENT. 10, 7, p. 826-835  Abstract
83.
Relationship of sequence-specific transactivation and p53-regulated apoptosis in interleukin 3-dependent hematopoietic cells
Gottlieb E., Lindner S. & Oren M. (1996) Cell Growth & Differentiation. 7, 3, p. 301-310  Abstract
82.
Rowan S., Ludwig R., Haupt Y., Bates S., Lu X., Oren M. & Vousden K. (1996) EMBO Journal. 15, 4, p. 827-838  Abstract
81.
p53-Mediated apoptosis - Regulatory and mechanistic aspects
Haupt Y., Rowan S., Shaulian E., Gottlieb E., YonishRouach E., Vousden K. & Oren M. (1996) Cancer Genes: Functional Aspects. 7, p. 83-101  Abstract

1995

80.
E2F-1:DP-1 Induces p53 and Overrides Survival Factors To Trigger Apoptosis
HIEBERT S., PACKHAM G., STROM D., HAFFNER R., Oren M., ZAMBETTI G. & CLEVELAND J. (1995) Molecular and Cellular Biology. 15, 12, p. 6864-6874  Abstract
79.
STUART E., HAFFNER R., Oren M. & GRUSS P. (1995) EMBO Journal. 14, 22, p. 5638-5645  Abstract
78.
Cancer: The translation of advances in basic science to human therapy. 22-27 July, 1995 - La fondation des Treilles, Tourtour, France - Discussion
Harlow E., Tlsty T., Courtneidge S. et al. (1995) Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences. 318, 11, p. 1173-1179  Abstract
[All authors]
77.
MALCOMSON R., Oren M., WYLLIE A. & HARRISON D. (1995) British Journal of Cancer. 72, 4, p. 952-957  Abstract
76.
HAUPT Y., ROWAN S., SHAULIAN E., VOUSDEN K. & Oren M. (1995) GENES & DEVELOPMENT. 9, 17, p. 2170-2183  Abstract
75.
Zauberman A., FLUSBERG D., HAUPT Y., Barak Y. & Oren M. (1995) Nucleic Acids Research. 23, 14, p. 2584-2592  Abstract
74.
IDENTIFICATION OF P53 TARGET GENES THROUGH IMMUNE SELECTION OF GENOMIC DNA - THE CYCLIN-G GENE CONTAINS 2 DISTINCT P53 BINDING-SITES
Zauberman A., LUPO A. & Oren M. (1995) Oncogene. 10, 12, p. 2361-2366  Abstract
73.
KERENTAL I., SUH B., Dantes A., LINDNER S., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 283-295  Abstract
72.
AHARONI D., Dantes A., Oren M. & Amsterdam A. (1995) Experimental Cell Research. 218, 1, p. 271-282  Abstract
71.
P53-MEDIATED APOPTOSIS IN HELA-CELLS CAN BE OVERCOME BY EXCESS PRB
HAUPT Y., ROWAN S. & Oren M. (1995) Oncogene. 10, 8, p. 1563-1571  Abstract
70.
NON-SYNTENIC AMPLIFICATION OF MDM2 AND MYCN IN HUMAN NEUROBLASTOMA
CORVI R., SAVELYEVA L., BREIT S., WENZEL A., HANDGRETINGER R., BARAK J., Oren M., AMLER L. & SCHWAB M. (1995) Oncogene. 10, 6, p. 1081-1086  Abstract
69.
EIZENBERG O., FABER-ELMAN A., GOTTLIEB E., Oren M., Rotter V. & Schwartz M. (1995) EMBO Journal. 14, 6, p. 1136-1144  Abstract
68.
TRANSCRIPTIONAL REPRESSION BY THE C-TERMINAL DOMAIN OF P53
SHAULIAN E., HAVIV I., Shaul Y. & Oren M. (1995) Oncogene. 10, 4, p. 671-680  Abstract

1994

67.
Barak Y., GOTTLIEB E., JUVENGERSHON T. & Oren M. (1994) GENES & DEVELOPMENT. 8, 15, p. 1739-1749  Abstract
66.
RELATIONSHIP OF P53 TO THE CONTROL OF APOPTOTIC CELL-DEATH
Oren M. (1994) Seminars in Cancer Biology. 5, 3, p. 221-227  Abstract
65.
Degradation of the tumor suppressor protein p53 by the ubiquitin-mediated proteolytic system requires a novel species of ubiquitin-carrier protein, E2
CIECHANOVER A., SHKEDY D., Oren M. & BERCOVICH B. (1994) Journal of Biological Chemistry. 269, 13, p. 9582-9589  Abstract
64.
GOTTLIEB E., HAFFNER R., VON RUDEN T., WAGNER E. & Oren M. (1994) EMBO Journal. 13, 6, p. 1368-1374  Abstract
63.
TARGETS FOR TRANSCRIPTIONAL ACTIVATION BY WILD-TYPE P53 - ENDOGENOUS RETROVIRAL LTR, IMMUNOGLOBULIN-LIKE PROMOTER, AND AN INTERNAL PROMOTER OF THE MDM2 GENE
Barak Y., LUPO A., Zauberman A., JUVEN T., ALONIGRINSTEIN R., GOTTLIEB E., Rotter V. & Oren M. (1994) Cold Spring Harbor Symposia on Quantitative Biology. 59, p. 225-235  Abstract
62.
WILD-TYPE P(53) ACTIVITY CONTRIBUTES TO DEPENDENCE ON HEMATOPOIETIC SURVIVAL FACTORS
GOTTLIEB E., HAFFNER R., YONISHROUACH E., VONRUDEN T., WAGNER E. & Oren M. (1994) Apoptosis. 5, p. 31-45  Abstract

1993

61.
Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene
JUVEN T., Barak Y., Zauberman A., GEORGE D. & Oren M. (1993) Oncogene. 8, 12, p. 3411-3416  Abstract
60.
COMPLEMENTATION BY WILD-TYPE P53 OF INTERLEUKIN-6 EFFECTS ON M1 CELLS - INDUCTION OF CELL-CYCLE EXIT AND COOPERATIVITY WITH C-MYC SUPPRESSION
Levy N., YONISHROUACH E., Oren M. & Kimchi A. (1993) Molecular and Cellular Biology. 13, 12, p. 7942-7952  Abstract
59.
Telerman A., TUYNDER M., DUPRESSOIR T., ROBAYE B., SIGAUX F., SHAULIAN E., Oren M., ROMMELAERE J. & AMSON R. (1993) Proceedings of the National Academy of Sciences of the United States of America. 90, 18, p. 8702-8706  Abstract
58.
Zauberman A., Barak Y., RAGIMOV N., Levy N. & Oren M. (1993) EMBO Journal. 12, 7, p. 2799-2808  Abstract
57.
SHAULIAN E., Zauberman A., MILNER J., DAVIES E. & Oren M. (1993) EMBO Journal. 12, 7, p. 2789-2797  Abstract
56.
ALONI, YOSEF - (1936-1993) - OBITUARY
Oren M. (1993) Oncogene. 8, 6, p. 1405-1405  Abstract
55.
Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif
RAGIMOV N., KRAUSKOPF A., NAVOT N., Rotter V., Oren M. & ALONI Y. (1993) Oncogene. 8, 5, p. 1183-1193  Abstract
54.
P53-MEDIATED CELL-DEATH - RELATIONSHIP TO CELL-CYCLE CONTROL
YONISHROUACH E., GRUNWALD D., Wilder S., Kimchi A., MAY E., LAWRENCE J., MAY P. & Oren M. (1993) Molecular and Cellular Biology. 13, 3, p. 1415-1423  Abstract
53.
Barak Y., JUVEN T., HAFFNER R. & Oren M. (1993) EMBO Journal. 12, 2, p. 461-468  Abstract

1992

52.
IDENTIFICATION OF A MINIMAL TRANSFORMING DOMAIN OF P53 - NEGATIVE DOMINANCE THROUGH ABROGATION OF SEQUENCE-SPECIFIC DNA-BINDING
SHAULIAN E., Zauberman A., GINSBERG D. & Oren M. (1992) Molecular and Cellular Biology. 12, 12, p. 5581-5592  Abstract
51.
THE GENE FOR THE RAT HEAT-SHOCK COGNATE, HSC70, CAN SUPPRESS ONCOGENE-MEDIATED TRANSFORMATION
YEHIELY F. & Oren M. (1992) Cell Growth & Differentiation. 3, 11, p. 803-809  Abstract
50.
P53 - THE ULTIMATE TUMOR SUPPRESSOR GENE
Oren M. (1992) FASEB Journal. 6, 13, p. 3169-3176  Abstract
49.
Oren M. (1992) Cancer and Metastasis Reviews. 11, 2, p. 141-148  Abstract
48.
Yaacov B. & Oren M. (1992) EMBO Journal. 11, 6, p. 2115-2121  Abstract

1991

47.
EIZENBERG O. & Oren M. (1991) Biochimica Et Biophysica Acta. 1129, 1, p. 34-42  Abstract
46.
GINSBERG D., MECHTA F., Yaniv M. & Oren M. (1991) Proceedings of the National Academy of Sciences of the United States of America. 88, 22, p. 9979-9983  Abstract
45.
FREQUENT P53 MUTATIONS IN CHEMICALLY-INDUCED MURINE FIBROSARCOMA
Halevy O., RODEL J., Peled A. & Oren M. (1991) Oncogene. 6, 9, p. 1593-1600  Abstract
44.
SIMIAN VIRUS-40 CAN OVERCOME THE ANTIPROLIFERATIVE EFFECT OF WILD-TYPE-P53 IN THE ABSENCE OF STABLE LARGE T-ANTIGEN-P53 BINDING
Michael D., YEHIELY F., GOTTLIEB E. & Oren M. (1991) Journal of Virology. 65, 8, p. 4160-4168  Abstract
43.
YONISHROUACH E., RESNITZKY D., Lotem J., Sachs L., Kimchi A. & Oren M. (1991) Nature. 352, 6333, p. 345-347  Abstract
42.
TRANSFECTED MOUSE C-JUN CAN INHIBIT TRANSFORMATION OF PRIMARY RAT EMBRYO FIBROBLASTS
GINSBERG D., HIRAI S., PINHASIKIMHI O., Yaniv M. & Oren M. (1991) Oncogene. 6, 4, p. 669-672  Abstract
41.
Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein.
GINSBERG D., Michael D. & Oren M. (1991) Molecular and Cellular Biology. 11, 1, p. 582-585  Abstract
40.
MICHALOVITZ D., Halevy O. & Oren M. (1991) Journal of Cellular Biochemistry. 45, 1, p. 22-29  Abstract

1990

39.
Halevy O., MICHALOVITZ D. & Oren M. (1990) Science. 250, 4977, p. 113-116  Abstract
38.
PROTEIN-BINDING ELEMENTS IN THE PROMOTER REGION OF THE MOUSE P53 GENE
GINSBERG D., Oren M., Yaniv M. & PIETTE J. (1990) Oncogene. 5, 9, p. 1285-1290  Abstract
36.
p53 — Oncogene or Anti-Oncogene?
Eliyahu D., Michael D. Y., Eliyahu S., Pinchas-Kimhi O. & Oren M. (1990) Oncogenes in Cancer Diagnosis. Bartram CR., Munk K. & Schwab M.(eds.). p. 125-134  Abstract

1989

35.
Eliyahu D., MICHALOVITZ D., ELIYAHU S., PINHASIKIMHI O. & Oren M. (1989) Proceedings of the National Academy of Sciences of the United States of America. 86, 22, p. 8763-8767  Abstract
34.
STABILIZATION OF THE P53 TRANSFORMATION-RELATED PROTEIN IN MOUSE FIBRO-SARCOMA CELL-LINES - EFFECTS OF PROTEIN-SEQUENCE AND INTRACELLULAR ENVIRONMENT
Halevy O., HALL A. & Oren M. (1989) Molecular and Cellular Biology. 9, 8, p. 3385-3392  Abstract
33.
INTERACTIONS BETWEEN SV40 AND CELLULAR ONCOGENES IN THE TRANSFORMATION OF PRIMARY RAT-CELLS
MICHALOVITZ D., Amsterdam A. & Oren M. (1989) Current Topics in Microbiology and Immunology. 144, p. 63-75  Abstract

1988

32.
OLIGOMERIZATION OF ONCOPROTEIN-P53
KRAISS S., QUAISER A., Oren M. & MONTENARH M. (1988) Journal of Virology. 62, 12, p. 4737-4744  Abstract
31.
Amsterdam A., Zauberman A., Meir G., PINHASIKIMHI O., SUH B. & Oren M. (1988) Proceedings of the National Academy of Sciences of the United States of America. 85, 20, p. 7582-7586  Abstract
30.
METH-A FIBRO-SARCOMA CELLS EXPRESS 2 TRANSFORMING MUTANT P53 SPECIES
Eliyahu D., Goldfinger N., PINHASIKIMHI O., SHAULSKY G., SKURNIK Y., ARAI N., Rotter V. & Oren M. (1988) Oncogene. 3, 3, p. 313-321  Abstract
29.
ACTIVATING MUTATIONS FOR TRANSFORMATION BY P53 PRODUCE A GENE-PRODUCT THAT FORMS AN HSC70-P53 COMPLEX WITH AN ALTERED HALF-LIFE
FINLAY C., HINDS P., TAN T., Eliyahu D., Oren M. & LEVINE A. (1988) Molecular and Cellular Biology. 8, 2, p. 531-539  Abstract
28.
Complex Formation Between the p53 Cellular Tumor Antigen and Nuclear Heat Shock Proteins
Michalovitz (Michael) D., Pinhasi-Kimchi O., Eliyahu D., Ben-Ze'ev A. & Oren M. (1988) Cellular and Molecular Biology of Tumors and Potential Application. Liss A. R., Minna J. & Kuehl WM.(eds.). Vol. 56. p. 247-259 (trueUCLA Symposia on Molecular & Cellular Biology).  Abstract

1987

27.
Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts
MICHALOVITZ D., FISCHERFANTUZZI L., VESCO C., PIPAS J. & Oren M. (1987) Journal of Virology. 61, 8, p. 2648-2654  Abstract
26.
INHIBITION OF CELL-GROWTH MEDIATED BY PLASMIDS ENCODING P53 ANTISENSE
SHOHAT O., Greenberg M., REISMAN D., Oren M. & Rotter V. (1987) Oncogene. 1, 3, p. 277-283  Abstract

1986

25.
Overproduction of protein p53 contributes to simian virus 40-mediated transformation
MICHALOVITZ D., Eliyahu D. & Oren M. (1986) Molecular and Cellular Biology. 6, 10, p. 3531-3536  Abstract
24.
PINHASIKIMHI O., MICHALOVITZ D., Ben-Ze'ev A. & Oren M. (1986) Nature. 320, 6058, p. 182-185  Abstract
23.
KACZMAREK L., Oren M. & BASERGA R. (1986) Experimental Cell Research. 162, 1, p. 268-272  Abstract
22.
MOAV B., HOROWITZ M., COHEN J., RECHAVI G., Eliyahu E., Oren M. & Givol D. (1986) Gene. 48, 3-Feb, p. 297-300  Abstract

1985

21.
BIENZ-TADMOR B., ZAKUT-HOURI R., LIBRESCO S., Givol D. & Oren M. (1985) EMBO Journal. 4, 12, p. 3209-3213  Abstract
20.
Eliyahu D., Michalovitz D. & Oren M. (1985) Nature. 316, 6024, p. 158-160  Abstract
19.
ZAKUT-HOURI R., BIENZ-TADMOR B., Givol D. & Oren M. (1985) EMBO Journal. 4, 5, p. 1251-1255  Abstract
18.
Oren M. (1985) Biochimica Et Biophysica Acta. 823, 1, p. 67-78  Abstract
17.
P53 CELLULAR TUMOR-ANTIGEN - ANALYSIS OF MESSENGER-RNA LEVELS IN NORMAL ADULT TISSUES, EMBRYOS, AND TUMORS
ROGEL A., Popliker M., WEBB C. & Oren M. (1985) Molecular and Cellular Biology. 5, 10, p. 2851-2855  Abstract
16.
LEBEAU M., WESTBROOK C., DIAZ M., ROWLEY J. & Oren M. (1985) Nature. 316, 6031, p. 826-828  Abstract

1984

15.
WOLF D., ADMON S., Oren M. & Rotter V. (1984) Molecular and Cellular Biology. 4, 3, p. 552-558  Abstract
14.
THE GENE AND THE PSEUDOGENE FOR MOUSE P53 CELLULAR TUMOR-ANTIGEN ARE LOCATED ON DIFFERENT CHROMOSOMES
CZOSNEK H., BIENZ B., Givol D., ZAKUTHOURI R., PRAVTCHEVA D., RUDDLE F. & Oren M. (1984) Molecular and Cellular Biology. 4, 8, p. 1638-1640  Abstract
13.
ANALYSIS OF THE GENE CODING FOR THE MURINE CELLULAR TUMOR-ANTIGEN P53
BIENZ B., ZAKUTHOURI R., Givol D. & Oren M. (1984) EMBO Journal. 3, 9, p. 2179-2183  Abstract
12.
Eliyahu D., Raz A., GRUSS P., Givol D. & Oren M. (1984) Nature. 312, 5995, p. 646-649  Abstract
11.
EXPRESSION OF THE MOUSE P53 CELLULAR TUMOR-ANTIGEN IN MONKEY CELLS
PINHASI O. & Oren M. (1984) Molecular and Cellular Biology. 4, 10, p. 2180-2186  Abstract

1983

10.
REICH N., Oren M. & LEVINE A. (1983) Molecular and Cellular Biology. 3, 12, p. 2143-2150  Abstract
9.
Oren M., BIENZ B., Givol D., RECHAVI G. & ZAKUT R. (1983) EMBO Journal. 2, 10, p. 1633-1639  Abstract
8.
ZAKUTHOURI R., Oren M., BIENZ B., LAVIE V., HAZUM S. & Givol D. (1983) Nature. 306, 5943, p. 594-597  Abstract
7.
Oren M. & LEVINE A. (1983) Proceedings Of The National Academy Of Sciences Of The United States Of America-Biological Sciences. 80, 1, p. 56-59  Abstract

1982

6.
DIFFERENT FORMS OF SIMIAN VIRUS-40 LARGE TUMOR-ANTIGEN VARYING IN THEIR AFFINITIES FOR DNA
GIDONI D., SCHELLER A., BARNET B., HANTZOPOULOS P., Oren M. & PRIVES C. (1982) Journal of Virology. 42, 2, p. 456-466  Abstract

1980